In addition, the over-expression of glucosylceramide synthase (GCS), the enzyme catalyzing the first reaction of ceramide (Cer) glycosylation, has been associated with drug-resistance and poor response to chemotherapy in a variety of cancers (for review see [18]). The gene discussed is UGCG; the disease is cancer.